标题
Management of cancer treatment-induced bone loss
作者
关键词
-
出版物
Nature Reviews Rheumatology
Volume 9, Issue 6, Pages 365-374
出版商
Springer Nature
发表日期
2013-03-19
DOI
10.1038/nrrheum.2013.36
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Overall survival with adjuvant zoledronic acid in patients with premenopausal breast cancer with complete endocrine blockade: Long-term results from ABCSG-12.
- (2017) M. Gnant et al. JOURNAL OF CLINICAL ONCOLOGY
- The economic burden of prostate cancer
- (2015) Claus G. Roehrborn et al. BJU INTERNATIONAL
- Intermittent and continuous androgen deprivation did not differ for mortality after radiotherapy for prostate cancer
- (2013) Martin R. Stockler ANNALS OF INTERNAL MEDICINE
- Calcium Intake and Risk of Cardiovascular Disease
- (2012) Lu Wang et al. American Journal of Cardiovascular Drugs
- Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
- (2012) R. Coleman et al. ANNALS OF ONCOLOGY
- S2-4: GAIN Study: A Phase III Trial To Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients with Node-Positive Primary Breast Cancer – 1st Interim Efficacy Analysis.
- (2012) V Möbus et al. CANCER RESEARCH
- Cancer treatment-induced bone loss in premenopausal women: A need for therapeutic intervention?
- (2012) P. Hadji et al. CANCER TREATMENT REVIEWS
- Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline
- (2012) Nelson B. Watts et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cost Effectiveness of Fracture Prevention in Postmenopausal Women Who Receive Aromatase Inhibitors for Early Breast Cancer
- (2012) Kouta Ito et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Dynamics of Bone Mineral Density During Intermittent Androgen Deprivation for Men With Nonmetastatic, Hormone-Sensitive Prostate Cancer
- (2012) Evan Y. Yu et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of Bone-Targeted Agents on Cancer Progression and Mortality
- (2012) R. Coleman et al. JNCI-Journal of the National Cancer Institute
- Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial
- (2012) Alexander HG Paterson et al. LANCET ONCOLOGY
- Denosumab in patients with cancer—a surgical strike against the osteoclast
- (2012) Janet E. Brown et al. Nature Reviews Clinical Oncology
- A Pooled Analysis of Vitamin D Dose Requirements for Fracture Prevention
- (2012) Heike A. Bischoff-Ferrari et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vitamin D and Breast Cancer
- (2012) T. Shao et al. ONCOLOGIST
- Calcium and Vitamin D Supplementation During Androgen Deprivation Therapy for Prostate Cancer: A Critical Review
- (2012) M. Datta et al. ONCOLOGIST
- Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment
- (2011) P. Hadji et al. ANNALS OF ONCOLOGY
- Strength training stops bone loss and builds muscle in postmenopausal breast cancer survivors: a randomized, controlled trial
- (2011) Kerri M. Winters-Stone et al. BREAST CANCER RESEARCH AND TREATMENT
- FRAX® with and without Bone Mineral Density
- (2011) John A. Kanis et al. CALCIFIED TISSUE INTERNATIONAL
- Pretreatment Serum Anti-Müllerian Hormone Predicts Long-Term Ovarian Function and Bone Mass after Chemotherapy for Early Breast Cancer
- (2011) Richard A. Anderson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Toremifene Decreases Vertebral Fractures in Men Younger Than 80 Years Receiving Androgen Deprivation Therapy for Prostate Cancer
- (2011) Matthew R. Smith et al. JOURNAL OF UROLOGY
- Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
- (2011) Matthew R Smith et al. LANCET
- Blockade of testicular and adrenal androgens in prostate cancer treatment
- (2011) Fernand Labrie Nature Reviews Urology
- Breast-Cancer Adjuvant Therapy with Zoledronic Acid
- (2011) Robert E. Coleman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates
- (2011) P. Hadji et al. OSTEOPOROSIS INTERNATIONAL
- Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis
- (2011) A Serpa Neto et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Long-term effects of anastrozole on bone mineral density: 7-year results from the ATAC trial
- (2010) R. Eastell et al. ANNALS OF ONCOLOGY
- OSTEOPOROSIS IN PATIENTS WITH PROSTATE CANCER ON LONG-TERM ANDROGEN DEPRIVATION THERAPY: AN INCREASING, BUT UNDER-RECOGNIZED PROBLEM
- (2010) Janet E. Brown et al. BJU INTERNATIONAL
- Reversal of skeletal effects of endocrine treatments in the Intergroup Exemestane Study
- (2010) Robert E. Coleman et al. BREAST CANCER RESEARCH AND TREATMENT
- Bone mineral density loss during adjuvant chemotherapy in pre-menopausal women with early breast cancer: is it dependent on oestrogen deficiency?
- (2010) David A. Cameron et al. BREAST CANCER RESEARCH AND TREATMENT
- Changes to Adjuvant Systemic Therapy in Breast Cancer: A Decade in Review
- (2010) Christina A. Saurel et al. Clinical Breast Cancer
- Effects of a Structured Weight-Bearing Exercise Program on Bone Metabolism Among Breast Cancer Survivors: A Feasibility Trial
- (2010) Luke J. Peppone et al. Clinical Breast Cancer
- Perspective how many women have osteoporosis?
- (2010) L. Joseph Melton et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Prevention of Aromatase Inhibitor–Induced Bone Loss Using Risedronate: The SABRE Trial
- (2010) Catherine Van Poznak et al. JOURNAL OF CLINICAL ONCOLOGY
- Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
- (2010) Matthew R. Smith et al. JOURNAL OF UROLOGY
- Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values
- (2009) Vivek K. Wadhwa et al. BJU INTERNATIONAL
- The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer
- (2009) Peyman Hadji et al. EUROPEAN JOURNAL OF CANCER
- Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature
- (2009) Per-Anders Abrahamsson EUROPEAN UROLOGY
- The Effects of Serum Testosterone, Estradiol, and Sex Hormone Binding Globulin Levels on Fracture Risk in Older Men
- (2009) Erin S. LeBlanc et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
- (2009) Michael Gnant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effect of weight training on bone mineral density and bone turnover in postmenopausal breast cancer survivors with bone loss: a 24-month randomized controlled trial
- (2009) N. L. Waltman et al. OSTEOPOROSIS INTERNATIONAL
- Impact of Surgical and Medical Castration on Serum Testosterone Level in Prostate Cancer Patients
- (2009) Giacomo Novara et al. UROLOGIA INTERNATIONALIS
- Guidance for the management of breast cancer treatment-induced bone loss: A consensus position statement from a UK Expert Group
- (2008) David M. Reid et al. CANCER TREATMENT REVIEWS
- Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer
- (2008) J. E. Lester et al. CLINICAL CANCER RESEARCH
- Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer
- (2008) Georgiana K. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- Skeletal Health After Continuation, Withdrawal, or Delay of Alendronate in Men With Prostate Cancer Undergoing Androgen-Deprivation Therapy
- (2008) Susan L. Greenspan et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230
- (2008) Richard Eastell et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Risedronate for the Prevention of Bone Loss in Premenopausal Women Undergoing Chemotherapy for Primary Breast Cancer
- (2008) Stephanie L. Hines et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
- (2008) Michael Gnant et al. LANCET ONCOLOGY
- FRAX™ and the assessment of fracture probability in men and women from the UK
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now